Low Sodium Cooking Study

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the acceptance of a salt restricted diet cooked with a controlled amount of salt in patients with heart disease. Verifying if there is difference in the acceptance of the standard and hyposodic diets cooked with controlled amount of salt.

Clinical Trial Description

Patients will be randomized into two groups. Patients in group 1 will receive on the first day the standard hyposodic diet - cooked without salt, with 2g of salt (sachet) to be added by the patient at each meal (lunch and dinner). After the first day dinner, these patients will respond to the diet acceptance questionnaire. On the second day, patients in this same group will receive the hyposodic diet cooked with controlled amount of salt at lunch and dinner. The hyposodic diet cooked with controlled amount of salt is cooked with 2 grams of salt that is divided for all the preparations, according to standardized recipes. After dinner, the patients will respond again to the diet acceptance questionnaire, however referring to the diet received in this day.

Patients in group 2 will receive the same intervention, however changing the order of reception of the diets, so, on the first day they will receive the cooked hyposodic diet with controlled amount of salt and on the second day the standard hyposodic diet (salt sachet).

The questionnaire applied refers to the reasons for not accepting the diet. The same questionnaire will be applied twice for each patient, after each of the diets offered - standard hyposodic and hyposodic cooked with controlled amount of salt.

The amount of food that was ingested by the patients, for both diets, will be evaluated by weighing the food that remains in the thermal of each meal. Leftovers of the preparations should be stored properly in plastic bags, separated by patient and properly identified, to be weighed in an electronic scale and immediately discarded in an appropriate place. It will be noted how much the patient refused from each preparation, in grams. The value obtained will be subtracted from the quantity, in grams, of the same preparation offered to the patient. The result of this operation (amount in grams of the preparation accepted / ingested by the individual) will be converted into percent. To determine the weight of the sended food, a thermometer will be weighed, which will be sent on the day, according to the standard home measure used. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03481322
Study type	Interventional
Source	Instituto de Cardiologia do Rio Grande do Sul
Contact
Status	Completed
Phase	N/A
Start date	September 5, 2017
Completion date	July 10, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00001638` - Magnetic Resonance Imaging of the Blood Vessels of the Heart
Completed	`NCT02376244` - The Health Impact of High Intensity Exercise Training With Intervals During Cardiac Rehabilitation	N/A
Completed	`NCT02277379` - Prediction of Bleeding and Transfusion Outcomes and Assessment of Perioperative Platelet Reactivity in Cardiac Surgery	N/A
Completed	`NCT02523144` - Dexmedetomidine in Children Having Transthoracic Echocardiography	Phase 4
Completed	`NCT02045641` - Pleural and Pericardial Effusion Following Open Heart Surgery	N/A
Completed	`NCT01871090` - Remote Device Interrogation In The Emergency Department	N/A
Active, not recruiting	`NCT01400490` - Eicosapentaenoic Acid (EPA)and Docosahexaenoic Acid Study	N/A
Completed	`NCT01192360` - Dynamic Contrast Enhanced Magnetic Resonance Perfusion Imaging in Congenital Heart Disease and Lung Disease	Phase 3
Terminated	`NCT00935766` - Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries	Phase 3
Completed	`NCT00745446` - The Effect of a Retrofit Particle Trap on the Vascular Effects of Diesel Exhaust Inhalation	N/A
Completed	`NCT00140816` - Dairy Products and Metabolic Effects (Norwegian Part)	N/A
Completed	`NCT00178620` - Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization	Phase 4
Completed	`NCT00013949` - Cardiovascular Vulnerability to Particulate Exposure	N/A
Completed	`NCT01952171` - The Genetic Basis of Congenital Heart Disease in Africa
Recruiting	`NCT02933892` - Benefit of Transradial Approach in Chronic Kidney Disease Population Undergoing Cardiac Catheterization	Phase 4
Withdrawn	`NCT02838355` - Employing End Tidal Capnography in Continuous Flow Ventricular Assist Device Patients	N/A
Completed	`NCT02923518` - Cardiac Screening of Middle Aged and Older Women and Men (Master Athletes)
Terminated	`NCT02282163` - Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography	Phase 3
Active, not recruiting	`NCT02260466` - Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement.	N/A
Completed	`NCT02274220` - Feeding Study - Effects Post-cardiac Surgery	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.